The customer is a spin-out company established from a plant-science research institute, formed as a joint venture involving the institute, an affiliated research council and other research partners. The company produces proteins, metabolites and complex natural products — including pharmaceuticals, vaccines and antigens — using a patented plant-based expression technology developed at the affiliated institute. Rather than relying on yeast, bacterial or animal-cell cultures, the proteins are grown in plant tissue and then extracted from the leaves.
In 2016 the company built a new two-storey, roughly 1,000 m² bioscience R&D facility next to the affiliated institute. Construction ran from June 2016 with the building handed over around the turn of the year and the facility due to be fully operational by the end of March 2017. The build was delivered by the main contractor, with the customer's project manager coordinating the specialist process equipment on behalf of the affiliated institute.
That work brings a specific obligation: the liquid waste it generates cannot simply go to drain.